News & Press

Iovance Biotherapeutics Initiates Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma

August 31, 2022

First TIL Therapy BLA Submission Initiated with U.S. Food and Drug Administration with Complete BLA Submission on Track for Fourth Quarter 2022 On August 25, Iovance Biotherapeutics Inc. announced the initiation of a rolling Biologics License Applicati …

The Melanoma Research Foundation to Host the Philadelphia Miles for Melanoma 5K

August 18, 2022

Philadelphia, PA (August 18, 2022) – The Melanoma Research Foundation (MRF) is proud to announce the return of their Philadelphia Miles for Melanoma 5K, held Saturday, August 27, at Franklin Square, 8:30AM ET. The nationwide annual 5K event tours the c …

Melanoma Research Foundation Welcomes Wren Clair as Emcee of 2022 Twin Cities Miles for Melanoma 5K

August 11, 2022

Minneapolis Meteorologist Returns as Voice of 2022 Twin Cities Miles 5k Twin Cities, MN (August 11, 2022) – The Melanoma Research Foundation (MRF) is thrilled to announce that 5 Eyewitness News Evening Meteorologist, Wren Clair will host and emcee the …

Conquer Cancer, Melanoma Research Foundation Announce ASCO Registry Melanoma Research Grant Recipient

August 8, 2022

ALEXANDRIA, Va. – Conquer Cancer®, the ASCO Foundation, and the Melanoma Research Foundation (MRF) are pleased to announce Leslie K. Dennis, PhD, MS, of The University of Arizona, as the recipient of the 2022 ASCO Registry Melanoma Research Grant. Conq …

Erik Jones Foundation Marks One-Year Anniversary with Donation to Melanoma Research Foundation

August 7, 2022

$20,000 Raised by 3 Reasons to Race Event in May at Birch Run Speedway Benefits Largest Independent Organization Devoted to Melanoma BROOKLYN, Mich. (Aug. 7, 2022) – It was a year ago when NASCAR Cup Series driver Erik Jones launched his own charitable …